Clearside Biomedical Inc expected to post a loss of 8  cents a share - Earnings Preview

Clearside Biomedical,

10/05/2022 03:05

* Clearside Biomedical Inc  CLSD.OQ   CLSD.O  is expected
to show
a rise in quarterly revenue when it reports  results on May 11. 
    * The Alpharetta Georgia-based  company is expected to
report  a
8,355.9% increase in revenue to $2.875 million from $34 thousand
a year ago, according to the mean estimate from 4 analysts,
based on Refinitiv data. 
    * ​Refinitiv's mean analyst estimate for Clearside
Biomedical Inc
is for a loss of 8 cents per share. For the same quarter last
year, the company reported a loss of 13 cents per share.
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 4 "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Clearside
Biomedical Inc is $10​, above​ its last closing price of $1.46.
​​​
    * Previous quarterly performance (using preferred earnings
measure
in US dollars). ​

 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Dec. 31 2021  0.12        0.16       0.31      Beat    95.8
 Sep. 30 2021  -0.10       -0.08      -0.08     Met     5.9
 Jun. 30 2021  -0.13       -0.13      -0.11     Beat    14.3​
 Mar. 31 2021  -0.11       -0.10      -0.13     Missed  -32.7
 ​​Dec.        -0.11       -0.11      -0.14     Missed  -22.8
 31 2020                                                
 Sep. 30 2020  -0.11       -0.12      -0.05     Beat    57.1​
 Jun. 30 2020  -0.11       -0.12      -0.13     Missed  -9.6
 Mar. 31 2020  -0.09       -0.11      -0.07     Beat    38.6
 This summary was machine generated May 10 at 02:05 GMT.  All
figures in US dollars  unless otherwise stated